Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02993159
Title Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern University Chicago Illinois 60611 United States Details
Saint Elizabeth Medical Center South Edgewood Kentucky 41017 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Cleveland Clinic Cleveland Ohio 44106 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field